Applied Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Applied Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Applied Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 144M shares, a 59.2% increase year-over-year.
  • Applied Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 84.2M shares, a 123% increase from 2022.
  • Applied Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 37.8M shares, a 47.8% increase from 2021.
  • Applied Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 25.6M shares, a 16.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 144M +53.7M +59.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 144M +64.9M +82.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 125M +69M +122% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 84.2M +46.4M +123% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 90.7M +42.7M +88.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 79M +52.1M +194% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 56.4M +30.1M +115% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 37.8M +12.2M +47.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 48M +21.8M +83.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 26.9M +819K +3.14% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 26.2M +2.08M +8.62% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 25.6M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 26.2M +3.75M +16.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 26.1M +4.02M +18.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 24.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 22.4M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 22.1M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.